Activation of the MC1R and MC4R receptors can lead to anti-inflammatory actions, possibly lowering harmful immune responses
64 In contrast with prior anti-obesity medications, concerns about suicide intention have not been confirmed for GLP-1 RA therapy
Besides diabetes and obesity management, GLP-1 drugs have shown many other potential benefits including: Lowering blood pressure Improving lipid disorders Improving fatty liver disease Reducing cardiovascular risk Decreases inflammation Reducing risk of kidney disease It is common for patients starting GLP-1 therapy to experience side effects during the first few weeks, including nausea, vomiting, headache, dizziness, and diarrhea
Comparing them directly, as some marketing materials do, is misleading
Do not freeze reconstituted tirzepatide unless you have specific cryoprotectant additives and stability data that support doing so
As a gastroenterologist, what's compelling here is the mechanism and the simplicity